Deloitte to replicate Sheba medical innovation model globally

In November 2019, Sheba Medical Center officially launched Arch Innovation Center (Acceleration, Redesign, Collaboration), whose purpose was to promote cooperation between the hospital and the Israeli and international biomedical industry. Now Chiba has found a way to expand the scope of the center and take advantage of its innovative activity: the hospital has signed an agreement with the consulting firm Deloitte, which, under Chiba’s supervision, will learn the ARC model and implement it in hospitals around the world.

ARC is made up of startup campuses, mainly in the field of digital health. Two venture capital funds invest in companies associated with the hospital ecosystem, and a network of leading physicians around the world are partners in this activity. Every year, a conference is held in which these physicians discuss trends and challenges in medicine.

“No significant medical innovation activity can be conducted within the borders of a single country,” Professor Chuck Kress, director general of Sheba Medical Center told Globes. “The network quickly attracted good doctors, and also aroused the interest of hospitals around the world.”

“We never imagined how many people would approach us and say: Help us create a similar activity ourselves,” says Prof. Eyal Zimlichman, who is Director of Transformation and Head of Innovation at Sheba Medical Center, who founded ARC. “The first activity was in Ottawa, after that in London and Bahrain, and now in New Jersey and Chicago, and we also signed an agreement in Melbourne.”

When the activity began to attract a lot of management interest, Professor Chris said, the hospital decided to partially outsource it. “We conducted a tender among five leading global consulting firms, and Deloitte won,” he says.

In collaboration with Deloitte, Sheba is now compiling an “operational guide” for building innovation centers like ARC. Deloitte will hold the activity in the hospitals with support from Sheba. Each implementation will bring a financial return. The hospital is not prepared to price in the amounts, but Professor Chris says that as far as the main return is concerned, it is the dissemination of knowledge and the connections that will be created. “This way we open the world to Israeli startups that work with us,” says Prof. Zimlichman.

For every hospital and health system that chooses to implement the model, one such package will be devised, said Asif Dahar, vice president and head of the US Life Sciences and Healthcare Sector for Deloitte LLP, who came to Israel to sign the agreement. Commensurate with the size and current level of technological innovation and hospital resources.

The goal: 40 positions per year

“We believe that innovation in health will advance exponentially, in order to prevent health budgets from exploding and at the same time give everyone the right treatment regardless of geographical location,” adds Ilan Bernfeld, Chairman and CEO of Deloitte Israel.

Chris says there are currently seventeen requests from potential clients. “We want to get to 40 a year. It’s not out of the question: in India alone there are 30,000 hospitals, and the aim is to create centers like this in health systems that are also not classic hospitals.”

Published by Globes, Israel business news – en.globes.co.il – on June 13, 2023.

© Copyright Globes Publisher Itonut (1983) Ltd., 2023.